These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6616867)

  • 1. Mathematical studies of complement activation.
    Garrigue MA; Muh JP; Bardos P
    Clin Chim Acta; 1983 Aug; 132(2):117-25. PubMed ID: 6616867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of complement activity in turkeys: evidence for classical and alternative complement pathways.
    Ellis MG; Lamont SJ; Arp LH
    Poult Sci; 1989 May; 68(5):646-50. PubMed ID: 2666975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunochemical method for assessing the function of the alternative complement pathway.
    Yoshida K; Yukiyama Y; Hirose S
    Int Arch Allergy Appl Immunol; 1984; 75(2):173-8. PubMed ID: 6469388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
    Pham Huu T; Buriot D; Griscelli C
    Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation by aluminium and zirconium compounds.
    Ramanathan VD; Badenoch-Jones P; Turk JL
    Immunology; 1979 Aug; 37(4):881-8. PubMed ID: 500133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-complementary action of polymorphic "solubility forms" of particulate inulin.
    Cooper PD; Carter M
    Mol Immunol; 1986 Aug; 23(8):895-901. PubMed ID: 3796631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
    Auteria A; Laghi Pasini F; Di Perri T
    Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):7-10. PubMed ID: 6778918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of the activation of the human complement and coagulation systems by chloroquine.
    Ramanathan VD; Sengupta U
    Int J Immunopharmacol; 1985; 7(5):769-73. PubMed ID: 4044101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of complement activation.
    Lachmann PJ; Hughes-Jones NC
    Springer Semin Immunopathol; 1984; 7(2-3):143-62. PubMed ID: 6495149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies of the association of complement components and IgG-coated latex particles incubated in normal or complement-activated human serum.
    Hällgren R
    Clin Exp Immunol; 1981 Apr; 44(1):191-200. PubMed ID: 7261475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of killed Listeria monocytogenes with the mouse complement system.
    van Kessel KP; Antonissen AC; van Dijk H; Rademaker PM; Willers JM
    Infect Immun; 1981 Oct; 34(1):16-9. PubMed ID: 6795123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathway complement activation induces reductions in effective hepatic blood flow.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    Curr Surg; 1987; 44(4):304-8. PubMed ID: 3665580
    [No Abstract]   [Full Text] [Related]  

  • 20. Extracts of wheat gluten activate complement via the alternative pathway.
    Unsworth DJ; Würzner R; Brown DL; Lachmann PJ
    Clin Exp Immunol; 1993 Dec; 94(3):539-43. PubMed ID: 8252813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.